Quality and Safety
by Jenna Ogilvie | Apr 21, 2016 | Discussion Paper, Perspectives
Accountable Care Organizations The fragmented nature of the delivery and financing of health care in the United States, coupled with misdirected incentives dominating the payment structure, has driven national expenditures to be the highest in the world for...
by Jenna Ogilvie | Apr 6, 2016 | Discussion Paper, Perspectives
Introduction Today, team-based health care is no longer an innovation or even a choice. Increasingly, providers are using a team-based approach to deliver care, and the complexity of health problems facing many Americans, combined with the specialization of...
by Jenna Ogilvie | Mar 31, 2016 | Discussion Paper, Perspectives
Background Patients of low socioeconomic status (SES) are at higher risk than patients of greater means for hospitalization for conditions that can be addressed in the ambulatory setting (Kangovi et al., 2013; 2014). Patients of low SES are twice as likely as...
by Jenna Ogilvie | Feb 11, 2016 | Commentary, Perspectives
Unlike with most food additives, the safety evaluation of macronutrients poses a challenge to risk assessors because of their inherent nutritional value and relatively large dietary exposure. A safety assessment model of macronutrients based solely on...
by Jenna Ogilvie | Feb 8, 2016 | Discussion Paper, Perspectives
Introduction The long delay between the creation of new evidence for primary prevention by public health and widespread adoption into best practice by the health care system is well documented and a source of great frustration (Haynes and Haines, 1998). The...
by Laura DeStefano | Oct 20, 2015 | Discussion Paper, Perspectives
Abstract This paper offers a perspective with recommendations on opportunities for the private sector to improve road safety outcomes globally. Road safety has been recognized as an increasing public health burden that disproportionately affects low- and...
by Laura DeStefano | Sep 11, 2015 | Discussion Paper, Perspectives
Abstract Despite the fact that they have gone through a rigorous approval process, uncertainty about newly approved drugs always exists. The uncertainty is amplified when drugs are approved on preliminary or interim evidence (i.e., accelerated approval) or on...
by Laura DeStefano | Aug 26, 2015 | Discussion Paper, Perspectives
Abstract Dose Matters describes the concept of “population dose”—an approach to strengthening and evaluating the impact of complex multisector, multilevel, place-based initiatives. This discussion paper reports on what is promising about the approach while...
by Laura DeStefano | Apr 9, 2015 | Discussion Paper, Perspectives
Recognizing the challenges of improving health outcomes depends on a complex set of factors, many beyond the control of the health care system, a recent report from the Institute of Medicine (IOM) stresses the importance of population health measurement to...
by Jenna Ogilvie | Feb 11, 2015 | Discussion Paper, Perspectives
Background Patient waits have been a long-standing concern in health care. Waits occur throughout the continuum of care and are built into and budgeted for within day-to-day operations. The status quo is changing, however, as patient experience becomes linked...
Page 5 of 12« First«...34567...10...»Last »
